Utah Medical Products Inc (UTMD)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit Dividendenhistorie

Finanzdaten der Utah Medical Products Inc-Aktie (UTMD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.05% 11.34	12.33	12.51	12.87	12.52
Cost Of Revenue	12.63% 4.574	5.235	5.146	5.127	4.677
Gross Profit	4.68% 6.766	7.098	7.359	7.739	7.843
Operating Expenses	2.56% 2.883	2.811	3.39	3.314	3.404
Benefits Costs and Expenses	18.69% 6.542	8.046	8.57	8.666	8.306
Costs And Expenses	18.69% 6.542	8.046	8.57	8.666	8.306
Operating Income/Loss	9.42% 3.883	4.287	3.969	4.425	4.439
Income/Loss From Continuing Operations Before Tax	11.92% 4.798	4.287	4.781	5.172	5.119
Income Tax Expense/Benefit, Deferred	53.06% -0.192	-0.409	-0.147	-0.134	-0.003
Income Tax Expense/Benefit	15.18% 0.842	0.731	0.846	0.972	0.905
Income/Loss From Continuing Operations After Tax	7.72% 3.956	4.287	3.935	4.20	4.214
Net Income/Loss	7.72% 3.956	4.287	3.935	4.20	4.214
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3.618	-	3.629	3.628	3.628
Diluted Average Shares	361.90K% 3.618	-0.001	3.639	3.639	3.636
Basic Earnings Per Share	7.63% 1.09	1.18	1.08	1.16	1.16
Diluted Earnings Per Share	7.63% 1.09	1.18	1.08	1.15	1.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

AVTR

$21.21

0.90%

BAX

$29.50

2.08%

ALGN

$211.06

1.18%

HOLX

$71.65

1.26%

COO

$93.44

1.64%

WST

$331.40

1.34%